Metastatic Urethral Urothelial Carcinoma Recruiting Phase 1 Trials for Nivolumab (DB09035)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0110111 (Metastatic Urethral Urothelial Carcinoma) | Recruiting | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02496208 | Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors | Treatment |